← Who reports today · Health Care
WST earnings date & Q2 2026 results · West Pharmaceutical Services
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 07/23/2026
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. · Text: Wikipedia, CC BY-SA 4.0, abridged
More about the company
Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.
Key growth driver: Revenue growth of +14% y/y — the report gives no segment split, so the driver is the whole business. · by the Q2 2026 report
When is WST’s next earnings date?
Thursday, October 22, 2026estimated
Expected around Oct 22 — based on last year’s report on Oct 23, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once WST announces it.
Same quarter a year ago (ended September 30, 2025): revenue $805M, EPS (GAAP) $1.92
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does WST report? Usually before market open: the last 4 results releases reached the SEC at 7:14 am, 7:11 am, 7:21 am, 7:15 am ET.
Last report: Jul 23, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$872
+13.8%
Gross profit
$329
+20.2%
37.7% margin
Operating income
$179
+16.5%
20.5% margin
Net income
$154
+16.8%
$2.15/sh · 17.7% margin
Verdict: revenue grew 13.8% y/y to $872M, operating margin 20.5% vs 20.1%, net income $154M (+16.8% y/y).
Operating cash flow was $213.9 million and free cash flow was $128.0 million.
Source and notation
Source: West Pharmaceutical Services press release, 8-K EX-99.1 of 07/23/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
WST earnings history: past report dates
| Jul 23, 2026 Thu | 7:14 ambefore market open | Jun 30, 2026 | $872M+14% y/y | $2.15+18% y/y |
| Apr 23, 2026 Thu | 7:11 ambefore market open | Mar 31, 2026 | $845M+21% y/y | $1.92+56% y/y |
| Feb 12, 2026 Thu | 7:21 ambefore market open | Dec 31, 2025 | ≈$805M+8% y/y | ≈$1.82+2% y/y |
| Oct 23, 2025 Thu | 7:15 ambefore market open | Sep 30, 2025 | $805M+8% y/y | $1.92+4% y/y |
| Jul 24, 2025 Thu | 7:17 ambefore market open | Jun 30, 2025 | $767M+9% y/y | $1.82+21% y/y |
| Apr 24, 2025 Thu | 7:47 ambefore market open | Mar 31, 2025 | $698M+0% y/y | $1.23−21% y/y |
| Feb 13, 2025 Thu | 8:00 ambefore market open | Dec 31, 2024 | ≈$749M+2% y/y | ≈$1.78−3% y/y |
| Oct 24, 2024 Thu | 7:50 ambefore market open | Sep 30, 2024 | $747M−0% y/y | $1.85−14% y/y |
| Jul 25, 2024 Thu | 8:05 ambefore market open | Jun 30, 2024 | $702M−7% y/y | $1.51−27% y/y |
| Apr 25, 2024 Thu | 7:42 ambefore market open | Mar 31, 2024 | $695M−3% y/y | $1.55−16% y/y |
| Feb 15, 2024 Thu | 7:51 ambefore market open | Dec 31, 2023 | ≈$732M+3% y/y | ≈$1.83+34% y/y |
| Oct 26, 2023 Thu | 7:41 ambefore market open | Sep 30, 2023 | $747M+9% y/y | $2.14+35% y/y |
| Jul 27, 2023 Thu | 7:46 ambefore market open | Jun 30, 2023 | $754M−2% y/y | $2.06−17% y/y |
| Apr 27, 2023 Thu | 8:04 ambefore market open | Mar 31, 2023 | $717M−0% y/y | $1.85−19% y/y |
| Feb 16, 2023 Thu | 7:40 ambefore market open | Dec 31, 2022 | ≈$709M−3% y/y | ≈$1.37−28% y/y |
| Oct 27, 2022 Thu | 7:50 ambefore market open | Sep 30, 2022 | $687M−3% y/y | $1.59−31% y/y |
| Jul 28, 2022 Thu | 7:37 ambefore market open | Jun 30, 2022 | $771M+7% y/y | $2.48+0% y/y |
| Apr 28, 2022 Thu | 7:52 ambefore market open | Mar 31, 2022 | $720M+7% y/y | $2.29+15% y/y |
| Feb 17, 2022 Thu | 7:51 ambefore market open | Dec 31, 2021 | ≈$731M+26% y/y | ≈$1.89+47% y/y |
| Oct 28, 2021 Thu | 8:17 ambefore market open | Sep 30, 2021 | $707M+29% y/y | $2.31+112% y/y |
| Jul 29, 2021 Thu | 8:07 ambefore market open | Jun 30, 2021 | $724M+37% y/y | $2.47+104% y/y |
| Apr 29, 2021 Thu | 7:20 ambefore market open | Mar 31, 2021 | $671M+36% y/y | $1.99+101% y/y |
| Feb 18, 2021 Thu | 7:39 ambefore market open | Dec 31, 2020 | $580M+23% y/y | $1.29+54% y/y |
| Oct 22, 2020 Thu | 7:34 ambefore market open | Sep 30, 2020 | $548M+20% y/y | $1.09+45% y/y |
| Jul 23, 2020 Thu | 8:25 ambefore market open | Jun 30, 2020 | $527M+12% y/y | $1.21+37% y/y |
| Apr 23, 2020 Thu | 6:51 ambefore market open | Mar 31, 2020 | $492M+11% y/y | $0.99+36% y/y |
| Feb 13, 2020 Thu | 9:14 ambefore market open | Dec 31, 2019 | ≈$471M+11% y/y | ≈$0.84+22% y/y |
| Oct 24, 2019 Thu | 8:58 ambefore market open | Sep 30, 2019 | $456M+6% y/y | $0.75+3% y/y |
| Jul 25, 2019 Thu | 9:00 ambefore market open | Jun 30, 2019 | $470M+5% y/y | $0.88+17% y/y |
| Apr 25, 2019 Thu | 9:05 ambefore market open | Mar 31, 2019 | $444M+7% y/y | $0.73+26% y/y |
| Feb 1, 2019 Fri | 5:20 pmafter market close | Dec 31, 2018 | ≈$423M+2% y/y | ≈$0.69 |
| Oct 25, 2018 Thu | 9:55 amduring market hours | Sep 30, 2018 | $432M+8% y/y | $0.73+9% y/y |
| Jul 26, 2018 Thu | 9:09 ambefore market open | Jun 30, 2018 | $448M+13% y/y | $0.75+47% y/y |
| Apr 26, 2018 Thu | 9:30 amduring market hours | Mar 31, 2018 | $416M+7% y/y | $0.58−28% y/y |
| Feb 15, 2018 Thu | 9:52 amduring market hours | Dec 31, 2017 | ≈$416M+9% y/y | ≈$0.00 |
| Oct 26, 2017 Thu | 10:01 amduring market hours | Sep 30, 2017 | $398M+6% y/y | $0.67+34% y/y |
| Jul 27, 2017 Thu | 9:14 ambefore market open | Jun 30, 2017 | $398M+2% y/y | $0.51−15% y/y |
| Apr 27, 2017 Thu | 8:29 ambefore market open | Mar 31, 2017 | $388M+7% y/y | $0.81+170% y/y |
| Feb 16, 2017 Thu | 8:26 ambefore market open | Dec 31, 2016 | ≈$382M+6% y/y | ≈$0.51+13% y/y |
| Oct 27, 2016 Thu | 9:03 ambefore market open | Sep 30, 2016 | $377M+9% y/y | $0.50 |
| Jul 28, 2016 Thu | 8:54 ambefore market open | Jun 30, 2016 | $388M+8% y/y | $0.60+58% y/y |
| Apr 28, 2016 Thu | 9:00 ambefore market open | Mar 31, 2016 | $362M+8% y/y | $0.30−33% y/y |
| Feb 18, 2016 Thu | 9:05 ambefore market open | Dec 31, 2015 | ≈$360M+3% y/y | ≈$0.45+5% y/y |
| Oct 29, 2015 Thu | 8:59 ambefore market open | Sep 30, 2015 | $345M−3% y/y | $0.02−95% y/y |
| Jul 30, 2015 Thu | 9:01 ambefore market open | Jun 30, 2015 | $360M−2% y/y | $0.38−27% y/y |
| Apr 30, 2015 Thu | 9:10 ambefore market open | Mar 31, 2015 | $336M−3% y/y | $0.45+18% y/y |
| Feb 19, 2015 Thu | 9:01 ambefore market open | Dec 31, 2014 | ≈$350M+2% y/y | ≈$0.43+34% y/y |
| Oct 15, 2014 Wed | 9:14 ambefore market open | Sep 30, 2014 | $356M+4% y/y | $0.43+16% y/y |
| Jul 31, 2014 Thu | 8:55 ambefore market open | Jun 30, 2014 | $369M+7% y/y | $0.52+21% y/y |
| May 1, 2014 Thu | 8:59 ambefore market open | Mar 31, 2014 | $347M+2% y/y | $0.38−16% y/y |
| Feb 20, 2014 Thu | 9:21 ambefore market open | Dec 31, 2013 | ≈$343M+7% y/y | ≈$0.32+7% y/y |
| Oct 31, 2013 Thu | 8:55 ambefore market open | Sep 30, 2013 | $342M+13% y/y | $0.37+76% y/y |
| Aug 1, 2013 Thu | 9:05 ambefore market open | Jun 30, 2013 | $345M+6% y/y | $0.43+87% y/y |
| May 2, 2013 Thu | 8:47 ambefore market open | Mar 31, 2013 | $339M+7% y/y | $0.45+10% y/y |
| Feb 21, 2013 Thu | 8:56 ambefore market open | Dec 31, 2012 | ≈$322M+9% y/y | ≈$0.30+11% y/y |
| Nov 1, 2012 Thu | 9:13 ambefore market open | Sep 30, 2012 | $304M+3% y/y | $0.21−16% y/y |
| Aug 2, 2012 Thu | 8:56 ambefore market open | Jun 30, 2012 | $325M+5% y/y | $0.23−18% y/y |
| Apr 17, 2012 Tue | 8:56 ambefore market open | Mar 31, 2012 | $316M+7% y/y | $0.41+46% y/y |
| Feb 16, 2012 Thu | 9:04 ambefore market open | Dec 31, 2011 | ≈$295M | ≈$0.27 |
| Nov 1, 2011 Tue | 8:51 ambefore market open | Sep 30, 2011 | $294M | $0.25 |
Show all 60 reports since 2011Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
West Pharmaceutical Services: 15-year financials
| 2025 | 3,074 | 585 | 494 | 469 | 61.2 |
| 2024 | 2,893 | 570 | 493 | 276 | 59.1 |
| 2023 | 2,950 | 676 | 593 | 415 | 57 |
| 2022 | 2,887 | 734 | 586 | 439 | 54.1 |
| 2021 | 2,832 | 752 | 662 | 331 | 51.1 |
| 2020 | 2,147 | 407 | 346 | 298 | 48.1 |
| 2019 | 1,840 | 297 | 242 | 241 | 45.1 |
| 2018 | 1,717 | 240 | 207 | 184 | 42.1 |
| 2017 | 1,599 | 226 | 151 | 133 | 39.1 |
| 2016 | 1,509 | 195 | 144 | 49.2 | 35.8 |
| 2015 | 1,400 | 129 | 95.6 | 80.8 | 32.4 |
| 2014 | 1,421 | 182 | 127 | 71 | 29.1 |
| 2013 | 1,368 | 162 | 112 | 68.6 | 26.7 |
| 2012 | 1,266 | 135 | 80.7 | 56.1 | 24.9 |
| 2011 | 1,192 | 110 | 75.5 | 35.3 | 23.2 |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $3.0B (73% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies with no net debt · S&P 500 companies that paid dividends 10 years without a gap · Piotroski F-score: S&P 500 companies scoring 8 or 9
West Pharmaceutical Services (WST) earnings: FAQ
When is WST's next earnings date?
We have not yet seen an announcement of the date from West Pharmaceutical Services (WST). Based on last year's report on Oct 23, 2025, the next report is expected around Oct 22, 2026.
What time does WST report earnings?
West Pharmaceutical Services usually reports before market open: its latest results release was filed with the SEC at 7:14 am ET on Jul 23, 2026.
When did WST last report earnings?
West Pharmaceutical Services reported Q2 2026 results on Jul 23, 2026.
Where can I find West Pharmaceutical Services's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to WST's filings; this page breaks the latest report down in a Sankey chart.
What was WST's net income in Q2 2026?
West Pharmaceutical Services reported net income of $154M for Q2 2026 (+16.8% year over year), under US GAAP.
Does West Pharmaceutical Services pay dividends?
Yes. In 2025, West Pharmaceutical Services paid $61M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.
How has West Pharmaceutical Services's revenue changed since 2011?
Per its 10-K filings, revenue grew 2.6x: $1,192M in 2011 and $3,074M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: ZBH · Q2 2026 · ZTS · Q2 2026 · A · Q3 FY2026 · ABBV · Q2 2026 · ABT · Q2 2026 · ALGN · Q2 2026 · AMGN · Q2 2026 · BAX · Q2 2026 · BDX · Q3 FY2026 · BIIB · Q2 2026 · all reports